Risk of Major Adverse Cardiovascular Events and Thromboembolism Events in Patients with Psoriatic Arthritis on JAK Inhibitors: A Network Meta-Analysis

Abstract Objectives Our objective was to evaluate the comparative effects of five Janus kinase inhibitors (JAKis) with ten interventions, comparing their impact on major adverse cardiovascular events (MACE) and thromboembolism events (TE) in patients with psoriatic arthritis (PsA) through network me...

Full description

Bibliographic Details

Published in:	Rheumatology and Therapy
Main Authors:	Lin-Hong Shi, James Cheng-Chung Wei, William Tao-Hsin Tung
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2025-07-01
Subjects:	JAK inhibitor Psoriatic arthritis Major adverse cardiovascular events Thromboembolism events TNFi Network meta-analysis
Online Access:	https://doi.org/10.1007/s40744-025-00783-5